GC CELL CORPORATION
Cell and gene therapy specialist with integrated CDMO, bio-logistics, and cell banking.
144510 | KO
Overview
Corporate Details
- ISIN(s):
- KR7144510005
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 이현로30번길 107, 용인시
- Website:
- http://gccell.com/en/main.do
- Sector:
- Manufacturing
Description
GC CELL CORPORATION specializes in cell and gene therapy, providing a fully integrated value chain from research to commercialization. The company's core offerings include end-to-end Contract Development and Manufacturing Organization (CDMO) services for autologous and allogeneic cell therapies, comprehensive bio-logistics, and cell banking. Its integrated model supports partners throughout the entire drug life cycle, from initial development and manufacturing to clinical trials and commercial distribution. In addition to its service-based solutions, GC CELL develops proprietary cell therapy products, including Immuncell-LC, an adjuvant therapy for hepatocellular carcinoma. The company focuses on advancing treatments in areas such as immune-oncology and delivering customized solutions to enhance patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-02-02 00:00 |
기타경영사항(특허권취득)(자율공시)(키메라 항원 수용체 및 이를 발현하는 자연 살해 세포)
|
Korean | 5.5 KB | ||
| 2021-01-29 00:00 |
투자판단관련주요경영사항(CAR-NK 고형암 치료제 공동연구개발 계약 체결)
|
Korean | 8.1 KB | ||
| 2020-11-16 00:00 |
분기보고서 (2020.09)
|
Korean | 1.3 MB | ||
| 2020-10-28 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 18.0 KB | ||
| 2020-08-14 00:00 |
반기보고서 (2020.06)
|
Korean | 1.2 MB | ||
| 2020-07-28 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 18.4 KB | ||
| 2020-07-21 00:00 |
기타경영사항(특허권취득)(자율공시)(신규한 약물 전달용 조성물 및 이를 유효성분으로 포함하는 GM1 강글리오사이드증 치료용 약학적 조성물)
|
Korean | 5.6 KB | ||
| 2020-07-01 00:00 |
기타경영사항(특허권취득)(자율공시)
|
Korean | 5.4 KB | ||
| 2020-06-25 00:00 |
타법인주식및출자증권취득결정
|
Korean | 24.3 KB | ||
| 2020-06-18 00:00 |
기타경영사항(특허권취득)(자율공시)(T 세포를 이용한 자연살해세포의 배양방법)
|
Korean | 5.5 KB | ||
| 2020-05-15 00:00 |
분기보고서 (2020.03)
|
Korean | 1.2 MB | ||
| 2020-04-29 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 18.3 KB | ||
| 2020-03-30 00:00 |
사업보고서 (2019.12)
|
Korean | 1.5 MB | ||
| 2020-03-24 00:00 |
정기주주총회결과
|
Korean | 23.4 KB | ||
| 2020-03-16 00:00 |
감사보고서제출
|
Korean | 27.1 KB |
Automate Your Workflow. Get a real-time feed of all GC CELL CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GC CELL CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GC CELL CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
